Pleased to meet you, we are Galapagos, a dynamic growing Biotech company with offices across Europe and in US, headquartered in Mechelen, Belgium.
We are in the business of changing lives. Focusing on high unmet medical needs, we synergize compelling science, technology, and collaborative approaches to create a deep pipeline of best-in-class small molecules, CAR-T therapies and biologics in oncology and immunology. With capabilities from lab to patient, including a decentralized, point-of-care CAR-T manufacturing network, we are committed to challenging the status quo and delivering results for our patients, employees and shareholders.
We pioneer for patients. We need thought leaders and rapid thinkers, entrepreneurs in spirit and status quo-fighters. Collaborative innovators and perseverant idealists. We need the best-in-class. In other words, we need you : The ‘make-it-happener’.
We are looking for a
Head Cell Therapy CMC Development Strategy in Leiden (NL).
Scope of the role:
As the Head of Cell Therapy CMC Development and Strategy, you will lead our team in developing and executing strategies for manufacturing cell therapies in our decentralized model. With a focus on driving innovation and excellence, this role is instrumental in advancing our cell therapy pipeline from early development through regulatory approval.
Your role: